Academic Journal
Q3US Endocrinology
About US Endocrinology
About US Endocrinology
US Endocrinology is a peer-reviewed scholarly journal published by 2833 (United Kingdom). It focuses on Q3. Publication coverage spans 2007-2025.
Key indicators: ISSN 1758-3918, 1758-3926; H-index 11.
Understanding This Journal's Metrics
Journal metrics help researchers assess fit, but they must be interpreted in context:
- H-index (11): 11 articles have each received at least 11 citations, indicating growing recognition.
Publishing in US Endocrinology
When considering this journal, verify its current indexing status, editorial board, and recent publications to ensure it meets your needs for visibility and credibility.
- Scope fit: Confirm your research aligns with Q3. Off-scope manuscripts are typically desk-rejected quickly.
- Author guidelines: Follow formatting, reference style, and article-type requirements exactly — non-compliant manuscripts may be returned without review.
- Submission: Submit via the official journal website.
Is This Journal Right for Your Paper?
- Audience match: Will the journal's readers cite and build on your findings?
- Timeline: Higher-tier journals mean longer review and higher rejection risk. Balance prestige against your schedule.
- Indexing: Confirm indexing in Web of Science, Scopus, and PubMed (if biomedical) meets your institutional requirements.
- Open access needs: Check funder mandates and whether the journal offers compliant OA options.
Frequently Asked Questions
What is the ISSN of US Endocrinology?
1758-3918, 1758-3926.
Who publishes US Endocrinology?
2833.
What are US Endocrinology's metrics?
H-index 11.
Where do I submit to US Endocrinology?
Via the official website.
Is US Endocrinology peer-reviewed?
Yes — it is a peer-reviewed scholarly journal indexed in major academic databases.
Source-backed journal facts
Topics in published research
Diabetes Management and Research; Diabetes Treatment and Management; Pancreatic function and diabetes; Diabetes and associated disorders; Diet and metabolism studies; Diabetes, Cardiovascular Risks, and Lipoproteins.
OpenAlex classifies topics from published works. These topics are not the publisher’s official aims and scope.
Source: OpenAlex source record. Retrieved 2026-10-03. Source record updated 2026-09-28. OpenAlex metrics are different from SCImago metrics and the Clarivate Journal Impact Factor.
Journal Metrics
Quartile, SJR and the listed SCImago H-index use the 2025 imported SCImago dataset. A quartile may vary by subject category. Values without a source or reporting year are unverified historical entries. Verify the current Journal Impact Factor with Clarivate or the publisher before using it.
Aims & Scope
The publisher’s official aims and scope have not yet been verified for this profile. Use the journal website to check subject fit and accepted article types before submitting.
Recent Research Articles
Latest publications matched automatically by ISSN.
An Update on Immune Checkpoint Inhibitor-related Hypophysitis
Michael J Mortensen, Oliver Oatman
2020 · DOI: 10.17925/use.2020.16.2.117Prospective Multicenter Observational Study of Voglibose in Type 2 Diabetes—VICTORY
Sanjay Kalra, A Panneer Selvam
2020 · DOI: 10.17925/use.2020.16.1.31Genital Tuberculosis and its Impact on Male and Female Infertility
Sonia Malik
2020 · DOI: 10.17925/use.2020.16.2.97Clinical Practice Patterns of Polycystic Ovary Syndrome Among Doctors of Different Specialties—An Indian Perspective
Deep Dutta, Saptarshi Bhattacharya
2020 · DOI: 10.17925/use.2020.16.2.74Simultaneous Onset of Autoimmune Hyperthyroidism and Rheumatic Fever in an Adolescent Female—Case Report
Divya Vundamati, Sarah Tsai
2020 · DOI: 10.17925/use.2020.16.2.125The Association Between Abnormal Eating Behaviors, Body Mass Index, and Waist-to-Height Ratio Among University Students in Malaysia
Mona Mohamed Ibrahim Abdalla, Nahla Abduljaleel Alsaidi
2020 · DOI: 10.17925/use.2020.16.2.69Cortisol and COVID-19—Putting Undue Stress on the “Stress Hormone”
Rimesh Pal, Mainak Banerjee
2020 · DOI: 10.17925/use.2020.16.2.66Is the Ketogenic Diet an Effective and Safe Approach to Type 2 Diabetes Management and Weight Loss?
Deep Dutta, Soumitra Ghosh
2020 · DOI: 10.17925/use.2020.16.1.15Can Serum Cortisol Be Used To Monitor Patients With COVID-19?
Ashutosh Kumar, Chiman Kumari
2020 · DOI: 10.17925/use.2020.16.2.63Controversies and Pitfalls in the Diagnosis of Extrapulmonary Tuberculosis with a Focus on Genital Tuberculosis
Nalini Kaul Mahajan
2020 · DOI: 10.17925/use.2020.16.2.109Cost Comparison of Flash Continuous Glucose Monitoring with Self-monitoring of Blood Glucose in Adults with Type 1 or Type 2 Diabetes Using Intensive Insulin—From a US Private Payer Perspective
Lizheng Shi, Richard Hellmund
2020 · DOI: 10.17925/use.2020.16.1.24Case Reports of Familial Non-autoimmune Hyperthyroidism in Two Malaysian Families due to Germline-activating Mutations in the Thyrotropin Receptor Gene
Noor Shafina Mohd Nor, Wu Loo Ling
2020 · DOI: 10.17925/use.2020.16.1.42Effect of Genital Tuberculosis on Ovarian Reserve
Padma Rekha Jirge
2020 · DOI: 10.17925/use.2020.16.2.104Diabetes, Poverty, and Sustainable Foods
Diana L Malkin-Washeim, Christopher Vogliano
2020 · DOI: 10.17925/use.2020.16.1.11Acromegaly Due to McCune–Albright Syndrome
Martin J Rutkowski, Derek G Southwell
2020 · DOI: 10.17925/use.2020.16.1.47Endocrine and Metabolic Manifestations of Tuberculosis
Madhuri Patil
2020 · DOI: 10.17925/use.2020.16.2.88Dietary Practices During Common Religious Fasts in People with Type 2 Diabetes Mellitus Among Different Religions in North India—A Questionnaire-based Study
Lovely Gupta, Bhavneet Arora
2020 · DOI: 10.17925/use.2020.16.1.36Clinical Evidence and Proposed Mechanisms for Cardiovascular and Kidney Benefits from Glucagon-like Peptide-1 Receptor Agonists
Emily J Cox, Radica Z Alicic
2020 · DOI: 10.17925/use.2020.16.2.80Patient-centered Choice of Prandial Insulin
Sanjay Kalra, Vishal Bhatia
2019 · DOI: 10.17925/use.2019.15.1.20Once-weekly Dulaglutide and Major Cardiovascular Events—Results of the REWIND Trial
John Doupis
2019 · DOI: 10.17925/use.2019.15.2.65Reviews
Community Reviews
Version History
October 10, 2026 at 2:06 am
October 2, 2026